Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1995;15:918-923

This Article
Right arrow Full Text
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Russell, J. C.
Right arrow Articles by Bar-Tana, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Russell, J. C.
Right arrow Articles by Bar-Tana, J.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 1995;15:918-923.)
© 1995 American Heart Association, Inc.


Articles

Inhibition of Atherosclerosis and Myocardial Lesions in the JCR:LA-cp Rat by ß,ß'-Tetramethylhexadecanedioic Acid (MEDICA 16)

James C. Russell; Roger M. Amy; Sandra E. Graham; Peter J. Dolphin; George O. Wood; Jacob Bar-Tana

From the Departments of Surgery (J.C.R., S.E.G.) and Pathology (G.O.W.), University of Alberta, Edmonton; British Columbia Cancer Agency (R.M.A.), Vancouver; Department of Biochemistry (P.J.D.), Dalhousie University, Halifax, Nova Scotia, Canada; and Department of Human Nutrition and Metabolism (J.B.-T.), Hadassah Medical School, Hebrew University, Jerusalem, Israel.

Correspondence to Dr J.C. Russell, Department of Surgery, 275 Heritage Medical Research Centre, University of Alberta, Edmonton, Alberta T6G 2S2, Canada.

Abstract Atherosclerosis-prone, insulin-resistant JCR:LA-cp male rats were treated from 6 weeks to 39 weeks of age with ß,ß'-tetramethylhexadecanedioic acid (MEDICA 16). Body weights were reduced (13%, P<.001) at 36 weeks without any accompanying decrease in food consumption. The treatment did not cause any significant change in plasma glucose or fasting insulin concentrations. There was a significant decrease in the extreme hyperplasia of the islets of Langerhans (38%, P<.05). The marked VLDL hypertriglyceridemia was decreased by 70% (P<.001), with an accompanying significant reduction in cholesterol concentrations. The severity of raised atherosclerotic lesions on the aortic arch was very markedly reduced (P<.01) in treated rats. This was accompanied by a reduction (P<.01) in the incidence of ischemic myocardial lesions. We conclude that long-term (33 weeks) MEDICA 16 treatment of an animal model for the obesity/insulin-resistant/hyperlipidemic syndrome not only markedly improved lipid metabolism, but also inhibited the development of advanced cardiovascular disease.


Key Words: MEDICA 16 • myocardial lesions • hypertriglyceridemia • JCR:LA-cp rat • atherosclerosis




This article has been cited by other articles:


Home page
J. Nutr.Home page
Y. Wang, M. M. Jacome-Sosa, M. R. Ruth, S. D. Goruk, M. J. Reaney, D. R. Glimm, D. C. Wright, D. F. Vine, C. J. Field, and S. D. Proctor
Trans-11 Vaccenic Acid Reduces Hepatic Lipogenesis and Chylomicron Secretion in JCR:LA-cp Rats
J. Nutr., November 1, 2009; 139(11): 2049 - 2054.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
Y. Wang, J. Lu, M. R. Ruth, S. D. Goruk, M. J. Reaney, D. R. Glimm, D. F. Vine, C. J. Field, and S. D. Proctor
Trans-11 Vaccenic Acid Dietary Supplementation Induces Hypolipidemic Effects in JCR:LA-cp Rats
J. Nutr., November 1, 2008; 138(11): 2117 - 2122.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J. C. Russell, S. D. Proctor, S. E. Kelly, and D. N. Brindley
Pair feeding-mediated changes in metabolism: stress response and pathophysiology in insulin-resistant, atherosclerosis-prone JCR:LA-cp rats
Am J Physiol Endocrinol Metab, June 1, 2008; 294(6): E1078 - E1087.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
S. D. Proctor, K. L. Dreher, S. E. Kelly, and J. C. Russell
Hypersensitivity of Prediabetic JCR:LA-cp Rats to Fine Airborne Combustion Particle-Induced Direct and Noradrenergic-Mediated Vascular Contraction
Toxicol. Sci., April 1, 2006; 90(2): 385 - 391.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
Z. Q. Wang, X. H. Zhang, J. C. Russell, M. Hulver, and W. T. Cefalu
Chromium Picolinate Enhances Skeletal Muscle Cellular Insulin Signaling In Vivo in Obese, Insulin-Resistant JCR:LA-cp Rats
J. Nutr., February 1, 2006; 136(2): 415 - 420.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
C. T. Cramer, B. Goetz, K. L. M. Hopson, G. J. Fici, R. M. Ackermann, S. C. Brown, C. L. Bisgaier, W. G. Rajeswaran, D. C. Oniciu, and M. E. Pape
Effects of a novel dual lipid synthesis inhibitor and its potential utility in treating dyslipidemia and metabolic syndrome
J. Lipid Res., July 1, 2004; 45(7): 1289 - 1301.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
L. L. Atkinson, R. Kozak, S. E. Kelly, A. Onay-Besikci, J. C. Russell, and G. D. Lopaschuk
Potential mechanisms and consequences of cardiac triacylglycerol accumulation in insulin-resistant rats
Am J Physiol Endocrinol Metab, May 1, 2003; 284(5): E923 - E930.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
W. T. Cefalu, Z. Q. Wang, X. H. Zhang, L. C. Baldor, and J. C. Russell
Oral Chromium Picolinate Improves Carbohydrate and Lipid Metabolism and Enhances Skeletal Muscle Glut-4 Translocation in Obese, Hyperinsulinemic (JCR-LA Corpulent) Rats
J. Nutr., June 1, 2002; 132(6): 1107 - 1114.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
S. J. Netherton, S. L. Jimmo, D. Palmer, D. G. Tilley, H. A. Dunkerley, D. R. Raymond, J. C. Russell, P. M. Absher, E. H. Sage, R. B. Vernon, et al.
Altered Phosphodiesterase 3-Mediated cAMP Hydrolysis Contributes to a Hypermotile Phenotype in Obese JCR:LA-cp Rat Aortic Vascular Smooth Muscle Cells: Implications for Diabetes-Associated Cardiovascular Disease
Diabetes, April 1, 2002; 51(4): 1194 - 1200.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
M. Li, P. M. Absher, P. Liang, J. C. Russell, B. E. Sobel, and N. K. Fukagawa
High Glucose Concentrations Induce Oxidative Damage to Mitochondrial DNA in Explanted Vascular Smooth Muscle Cells
Experimental Biology and Medicine, May 1, 2001; 226(5): 450 - 457.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
J. C. Russell, D. Ravel, J.-P. Pégorier, P. Delrat, R. Jochemsen, S. F. O'Brien, S. E. Kelly, S. T. Davidge, and D. N. Brindley
Beneficial Insulin-Sensitizing and Vascular Effects of S15261 in the Insulin-Resistant JCR:LA-cp Rat
J. Pharmacol. Exp. Ther., November 1, 2000; 295(2): 753 - 760.
[Abstract] [Full Text]


Home page
Cardiovasc ResHome page
F. Brunner, G. Wolkart, S. Pfeiffer, J. C Russell, and T. C Wascher
Vascular dysfunction and myocardial contractility in the JCR:LA-corpulent rat
Cardiovasc Res, July 1, 2000; 47(1): 150 - 158.
[Abstract] [Full Text] [PDF]